Health Tidings Mergers & AcquisitionsGalapagos – Gilead Finalize Ouro-Linked Deal to Advance Gamgertamig Galapagos – Gilead Finalize Ouro-Linked Deal to Advance Gamgertamig Read Post »
Mergers & AcquisitionsLilly to Acquire Centessa in $6.3B Deal, Expands Orexin Pipeline for Sleep ... Lilly to Acquire Centessa in $6.3B Deal, Expands Orexin Pipeline for Sleep ... Read Post »
Health Tidings Mergers & AcquisitionsAfter NVIDIA, Lilly Signs New AI Drug Discovery Deal with Insilico After NVIDIA, Lilly Signs New AI Drug Discovery Deal with Insilico Read Post »
Mergers & AcquisitionsNovartis to Acquire Excellergy for Up to $2 Billion, Adds Next-Generation A... Novartis to Acquire Excellergy for Up to $2 Billion, Adds Next-Generation A... Read Post »
Mergers & AcquisitionsOtsuka to Acquire Transcend Therapeutics in Up to $1.2B Deal to Advance PTS... Otsuka to Acquire Transcend Therapeutics in Up to $1.2B Deal to Advance PTS... Read Post »
Health Tidings Mergers & AcquisitionsBiogen Signs Deal with Alteogen to Develop Subcutaneous Versions of Two Bio... Biogen Signs Deal with Alteogen to Develop Subcutaneous Versions of Two Bio... Read Post »
Mergers & AcquisitionsJanux Targets 2026 TRACTr Updates, Announces BMS Collaboration Janux Targets 2026 TRACTr Updates, Announces BMS Collaboration Read Post »
Health Tidings Mergers & AcquisitionsMerck to Buy Terns, Strengthening CML Pipeline with TERN-701 Merck to Buy Terns, Strengthening CML Pipeline with TERN-701 Read Post »
Health Tidings Mergers & AcquisitionsAlnylam, Viz.ai Partner to Advance AI Detection of ATTR-CM Alnylam, Viz.ai Partner to Advance AI Detection of ATTR-CM Read Post »
Mergers & Acquisitions Policy & AcquisitionsGilead to Acquire Ouro Medicines for $1.7B; Galapagos in Talks to Partner o... Gilead to Acquire Ouro Medicines for $1.7B; Galapagos in Talks to Partner o... Read Post »
Mergers & AcquisitionsSanofi Inks Up to $1.23B Licensing Deal for Kali Therapeutics’ Autoimmune... Sanofi Inks Up to $1.23B Licensing Deal for Kali Therapeutics’ Autoimmune... Read Post »
Health Tidings Policy & AcquisitionsOxford, Serum Institute Partner to Advance ChAdOx1 Nipah Vaccine Oxford, Serum Institute Partner to Advance ChAdOx1 Nipah Vaccine Read Post »
Health Tidings Policy & AcquisitionsNovartis Targets PIK3CA-Mutant Tumors With $3B Synnovation Deal for SNV4818 Novartis Targets PIK3CA-Mutant Tumors With $3B Synnovation Deal for SNV4818 Read Post »
Health Tidings Policy & AcquisitionsWhat Is FDA’s New Approach Methodologies (NAMs) Framework for Non-Animal ... What Is FDA’s New Approach Methodologies (NAMs) Framework for Non-Animal ... Read Post »
Mergers & AcquisitionsSandoz Bets on $320B Biosimilar Opportunity with New Samsung Bioepis Partne... Sandoz Bets on $320B Biosimilar Opportunity with New Samsung Bioepis Partne... Read Post »
Health Tidings Policy & AcquisitionsZydus’ Sentynl Licenses Progerinin from PRG S&T to Advance Rare Disea... Zydus’ Sentynl Licenses Progerinin from PRG S&T to Advance Rare Disea... Read Post »
Health Tidings Policy & AcquisitionsSamsung Bioepis Partners with G2GBIO to Develop Long-Acting Semaglutide Usi... Samsung Bioepis Partners with G2GBIO to Develop Long-Acting Semaglutide Usi... Read Post »
Health Tidings Policy & AcquisitionsRapport Therapeutics Partners with Tenacia to Develop RAP-219 for Neurologi... Rapport Therapeutics Partners with Tenacia to Develop RAP-219 for Neurologi... Read Post »
Health Tidings Policy & AcquisitionsNovo Nordisk Resolves GLP-1 Dispute with Hims & Hers, Expands Access to... Novo Nordisk Resolves GLP-1 Dispute with Hims & Hers, Expands Access to... Read Post »
Health Tidings Policy & AcquisitionsGSK Licenses Linerixibat to Alfasigma in Deal Worth Up to $690 Million GSK Licenses Linerixibat to Alfasigma in Deal Worth Up to $690 Million Read Post »
Health Tidings Policy & AcquisitionsTenaya Therapeutics and Alnylam Collaborate to Discover Genetic Targets for... Tenaya Therapeutics and Alnylam Collaborate to Discover Genetic Targets for... Read Post »
Health Tidings Policy & AcquisitionsServier Acquires Day One Biopharmaceuticals for $2.5 Billion to Bolster Rar... Servier Acquires Day One Biopharmaceuticals for $2.5 Billion to Bolster Rar... Read Post »
Health Tidings Policy & AcquisitionsSanofi Licenses Rovadicitinib from Sino Biopharm in $1.53B Global Deal Sanofi Licenses Rovadicitinib from Sino Biopharm in $1.53B Global Deal Read Post »
Health Tidings Policy & AcquisitionsDuvakitug Gets $400M Boost: Teva’s IBD Pivot with Blackstone Duvakitug Gets $400M Boost: Teva’s IBD Pivot with Blackstone Read Post »
Health Tidings Policy & AcquisitionsGSK Finalizes $2.2B RAPT Buyout: Ozureprubart Eyes Quarterly Dosing for Foo... GSK Finalizes $2.2B RAPT Buyout: Ozureprubart Eyes Quarterly Dosing for Foo... Read Post »
Policy & AcquisitionsUCB Bets Big on ATG-201: $1.1B License Deal with Antengene for B-Cell Autoi... UCB Bets Big on ATG-201: $1.1B License Deal with Antengene for B-Cell Autoi... Read Post »
Policy & AcquisitionsCullgen Joins Gyre in $300M Pact, Boosting Protein Degraders Cullgen Joins Gyre in $300M Pact, Boosting Protein Degraders Read Post »
Health Tidings Policy & AcquisitionsNovartis Finalizes $12B Avidity Buyout for AOC Muscle Tech Novartis Finalizes $12B Avidity Buyout for AOC Muscle Tech Read Post »
Health Tidings Policy & AcquisitionsEarendil Labs Secures $885M WuXiTecan-2 Rights from WuXi XDC Earendil Labs Secures $885M WuXiTecan-2 Rights from WuXi XDC Read Post »
Health Tidings Policy & AcquisitionsExclusive: Boehringer Ingelheim Acquires Sitryx Program in High-Value Autoi... Exclusive: Boehringer Ingelheim Acquires Sitryx Program in High-Value Autoi... Read Post »
Health Tidings Policy & AcquisitionsBeam Therapeutics Advances BEAM-304 for PKU and Pfizer Collaboration Beam Therapeutics Advances BEAM-304 for PKU and Pfizer Collaboration Read Post »
Health Tidings Policy & AcquisitionsNovo Nordisk Partners with Vivtex to Pioneer Oral Biologics for Obesity and... Novo Nordisk Partners with Vivtex to Pioneer Oral Biologics for Obesity and... Read Post »
Health Tidings Policy & AcquisitionsGSK Acquires 35Pharma for $950M to Advance HS235 in Pulmonary Hypertension ... GSK Acquires 35Pharma for $950M to Advance HS235 in Pulmonary Hypertension ... Read Post »
Health Tidings Policy & AcquisitionsAstellas and Vir Biotechnology Unite to Advance VIR-5500, a Next-Gen T-Cell... Astellas and Vir Biotechnology Unite to Advance VIR-5500, a Next-Gen T-Cell... Read Post »
Health Tidings Policy & AcquisitionsOrganon Licenses MIUDELLA®: New Hormone-Free Copper IUD Option Organon Licenses MIUDELLA®: New Hormone-Free Copper IUD Option Read Post »
Clinical Trials Policy & AcquisitionsGilead Snaps Up Arcellx, Eyes Anito-cel Approval in Multiple Myeloma Gilead Snaps Up Arcellx, Eyes Anito-cel Approval in Multiple Myeloma Read Post »
Health Tidings Policy & AcquisitionsNovartis Licenses UNP’s Macrocyclic Peptides in $1.8B CVD Collaborati... Novartis Licenses UNP’s Macrocyclic Peptides in $1.8B CVD Collaborati... Read Post »
Health Tidings Policy & AcquisitionsKidswell Bio and Treehill Launch Kidswell USA to Advance Cell Therapy for C... Kidswell Bio and Treehill Launch Kidswell USA to Advance Cell Therapy for C... Read Post »
Health Tidings Policy & AcquisitionsSanofi Closes Dynavax Deal, Expands Presence in Adult Vaccines Sanofi Closes Dynavax Deal, Expands Presence in Adult Vaccines Read Post »
Health Tidings Policy & AcquisitionsChugai Licenses Araris’ AraLinQ® Platform to Advance Next-Generation ADC... Chugai Licenses Araris’ AraLinQ® Platform to Advance Next-Generation ADC... Read Post »
Policy & Acquisitions ResearchMexico Partners with Moderna to Boost mRNA Manufacturing and Preparedness Mexico Partners with Moderna to Boost mRNA Manufacturing and Preparedness Read Post »
Policy & AcquisitionsLilly’s $2.4 Billion Orna Deal Signals Push into In Vivo CAR-T Therapies Lilly’s $2.4 Billion Orna Deal Signals Push into In Vivo CAR-T Therapies Read Post »
Food Policy & AcquisitionsNo to Artificial Colors, Yes to Natural Alternatives: What the New FDA Poli... No to Artificial Colors, Yes to Natural Alternatives: What the New FDA Poli... Read Post »
Policy & AcquisitionsIllumina Completes Acquisition of SomaLogic Illumina Completes Acquisition of SomaLogic Read Post »
Policy & AcquisitionsAstraZeneca Bets Big on Next-Gen Obesity Drugs With CSPC AstraZeneca Bets Big on Next-Gen Obesity Drugs With CSPC Read Post »
Policy & AcquisitionsModerna Partners with Recordati to Advance mRNA-3927 for Propionic Acidemia Moderna Partners with Recordati to Advance mRNA-3927 for Propionic Acidemia Read Post »
Policy & AcquisitionsUS Officially Exits WHO in January 2026: Funding Cuts, COVID Fallout, and G... US Officially Exits WHO in January 2026: Funding Cuts, COVID Fallout, and G... Read Post »
Policy & AcquisitionsAstraZeneca Commits $15 Billion to China Expansion by 2030, Boosting Cell T... AstraZeneca Commits $15 Billion to China Expansion by 2030, Boosting Cell T... Read Post »
Policy & AcquisitionsSeamless Therapeutics and Eli Lilly Partner to Advance Programmable Gene Ed... Seamless Therapeutics and Eli Lilly Partner to Advance Programmable Gene Ed... Read Post »
Policy & AcquisitionsSimcere Signs EUR 1.058B IBD Deal with Boehringer Ingelheim for SIM0709 Simcere Signs EUR 1.058B IBD Deal with Boehringer Ingelheim for SIM0709 Read Post »
